Overview: Diagnosis of Hepatitis C Virus Infection using Synthetic Peptides

References

• BARANY G, MERRIFIELD RB: Solid phase pep-tide synthesis. In: The Peptides. (1979) Gross E, Meienhofer J (Eds), Academic Press, New York, vol 2, pp1–284.
   Google Scholar
• FIELDS GB, NOBLE RL: Solid phase pep-tide synthesis utilizing 9-fluorenylmethoxy-carbonyl amino acids. Int. J. Peptide Protein Res. (1990) 35:161–214.
   PubMedGoogle Scholar
• BANKI K, MACEDA J, HURLEY E, ABLONCZY E, MATTSON DH, SZEGEDY L, HUNG C, PERL A: Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-IEDa protein: A possible au-toantigen for HTLV-I gag-reactive autoan-tibodies. Proc. Nan. Acad. Sci. USA (1992) 89:1939–1943
   PubMed Web of Science ®Google Scholar
• FIELDS GB, FIELDS CG: Solvation effects in solid phase peptide synthesis. J. Am. Chem. Soc. (1991) 113:4202–4207.
   Google Scholar
• VAN REGENMORTEL MHV, BRIAND JP, MULLER S, PLAUE S: Synthetic polyp eptides as antigens. (1988) Elsevier, Amsterdam, pp1–39.
   Google Scholar
• IVANOV VS, SWOROVA ZK, TCHIKIN LD, KOZHICHA T, IVANOVV T Effective method for synthetic peptide immobilization that increases the sensitivity and the specificity of ELISA procedures. J. Immunol. Meth. (1992) 153:229–233
   PubMedGoogle Scholar
• MARSDEN HS, OWSIANICA AM, GRAHAM S, MCLEAN GW, ROBERTSON CA, SUBAK-SHARPE JH: Advantages of branched peptides in serodiagnosis. Detection of HIV-specific an-tibodies and the use of glycine spacers to in-crease sensitivity. J. ImmunoL Meth. (1992) 147:65–72.
   Google Scholar
• TAM JP: Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic system. Proc. Natl. Acad. Sci. USA (1988) 85:5409–5413.
   PubMed Web of Science ®Google Scholar
• PosNErr DN, MCGRATH H, TAM JP: A novel method for producing anti-peptide antibod-ies. J. Biol. Chem. (1988) 263(4):1719–1725.
   PubMedGoogle Scholar
• PRINCE AM, BROTMAN B, GRADY GF, KUHNS WJ, HAZZI C, LEVINE RW, MILLIAN SJ: Long incubation post-transfusion hepatitis with-out serological evidence of exposure to hep-atitis B virus. Lancet (1974) 11:241–246.
   Google Scholar
• REYES, GR, PURDY MA, Kim JP, Lux KC, YOUNG LM, FRY ICE, BRADLEY DW: Isolation of a cDNA from the virus responsible for en-terically transmitted non-A, non-B hepatitis. Science (1990) 247:1335–1339.
   PubMed Web of Science ®Google Scholar
• DIENSTAG JL: Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical fea-tures. Gastroenterology (1983) 85:439–462.
   Google Scholar
• REESINK HW, VAN DER POEL CL: Blood transfusion and hepatitis: still a threat? Blut (1989) 58:1–6.
   PubMedGoogle Scholar
• CHoo QL, Kuo G, WEINER AJ, OVERBY LR, BRADLEY DW, HOUGHTON M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 244:359–362.
   PubMed Web of Science ®Google Scholar
• Kuo, G, Oloo QL, ALTER HJ, GIT'NICK GL, REDEKER AG, PURCELL RH, MIYAMURAT, DIENSTAG JL, ALTER MJ, STEVENS CE, TEGTMEIER GE, BONINO F, COLOMBO M, LEE WS, Kuo C, BERGER K, SHUSTER JR, OVERBY LR, BRADLEY DW, HOUGHTON M: An assay for circulating antibodies to a major etio-logic virus of human non-A, non-B hepatitis. Science (1989) 244:362–364.
   PubMed Web of Science ®Google Scholar
• OKAMOTO Hs OKADA S. SUGIYAMA Y, YOTSU-•• MOTO S. TANAKA T, YOSHIZAWA H, TSUDA F, MIYAICAWA Y, MAYUMI M: The 5'-termi-nal sequence of the hepatitis C virus genome. Japan. J. Exp. Med. (1990) 60:167–177.
   Google Scholar
• KATO N, HIJIKATA M, OOTSUYAMA Y, NAKA-GAWA M, OHKOSHI S, SUGIMURA T, SHIMOT-OHNO, K: Molecular cloning of the human hepatitis C virus genome from Japanese pa-tients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA (1990) 87:9524–9528.
   PubMed Web of Science ®Google Scholar
• CHOO QL, RICHMAN KH, HAN .IH, BERGER K, LEE C, DONG C, GALLEGOS C, COTT D, MEDINA-SELBY A, BARR PJ, WEINER AJ, BRADLEY DW, Kuo G, HOUGHTON M: Ge-netic organization and diversity of the hep-atitis C virus. Proc. Natl. Acad. Sci. USA (1991) 88:2451–2455.
   Google Scholar
• TAICAMIZAWA A, MORI C, FUKE I, MANABE S,MURAICAMI S. FUJITA J, ONISHI E, ANDOH T, YOSHIDA I, OKAYAMA H: Structure and or-ganization of the hepatitis C virus genome isolated from human carriers. J. ViroL (1991) 65:1105–1113.
   Google Scholar
• OGATA N, ALTER HJ, MILLER RH, PURCELL RH: Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl. Acad. Sci. USA (1991) 88:3392–3396.
   PubMed Web of Science ®Google Scholar
• HIJIICATA M, KATO N, OOTSUYAMA Y, NAKA-GAWA M, SHIMOTOHNO K: Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analy-sis. Proc. Natl. Acad. Sci. USA (1991) 88:5547–5551.
   PubMedGoogle Scholar
• ENOMOTO N, TAKADA A, NAKAO T, DATE T: There are two major types of hepatitis C virus in Japan. Biochem. Biophys. Res. Comm. (1990) 170(3):1021–1025.
   PubMedGoogle Scholar
• KATO N, HIJIKATA M, OOTSUYAMA Y, NAKA-GAWA M, OHKOSHI S, SHIMOTOHNO K: Se-quence diversity of hepatitis C viral genomes. Mol. Biol. Med. (1990) 7:495–501.
   PubMedGoogle Scholar
• NAKAO T, ENOMOTO N, TAKADA N, TAKADA A, DATE T: Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J. Gen. ViroL (1991) 72:2105–2112.
   PubMedGoogle Scholar
• TSUKIYAMA-KOHARA K, KOHARA M, YAMA-GUCHI K, MAKI N, TOYOSHIMA A, MIKI K, TANAKA S, HArroxi N, NOMOTO A: A sec-ond group of hepatitis C viruses. Virus Genes (1991) 5(3):243–254.
   PubMedGoogle Scholar
• INCHAUSPE G, ZEBEDEE S, LEE DH, SUGITANI M, NASOFF M, PRINCE AM: Genomic struc-ture of the human prototype strain H of hep-atitis C virus: comparison with American and Japanese isolates. Proc. Natl. Acad. Sci. USA (1991) 88:10292–10296.
   PubMedGoogle Scholar
• OKAMOTO H, OKADA S, SUGIYAMA Y, KURAI K, ItzuxA H, MACHEDA A, MIYAKAWA Y, MAYUMI M: Nucleotide sequence of the ge-nomic RNA of hepatitis C virus isolated from a human carrier: comparison with re-ported isolates for conserved and divergent regions. J. Gen. Virol. (1991) 72:2697–2704.
   PubMedGoogle Scholar
• CHAN SW, MCOMISH F, HOLMES EC, Dow B, PEUTHERER JF, FOLLET E, YAP PL, SIMMONDS P: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. (1992) 73:1131–1141.
   PubMed Web of Science ®Google Scholar
• MCFARLANE IG, SMITH HM, JOHNSON PJ, BRAY GP, VERGANI D, WILLIAMS R: Hepati-tis C virus antibodies in chronic active hep-atitis: pathogenic factor or false-positive re-sult? Lancet (1990) 335:754–757.
   PubMed Web of Science ®Google Scholar
• HOUSET C, HIRSCHAUER C, DEGOS F: False-positive anti-HCV in primary binary cirrho-sis. Ann. Intern. Med. (1991) 114:251.
   PubMedGoogle Scholar
• A= A, TALIANI G, DE BAC C, SEBAST1ANI A: Anti-HCV false positivity in malaria. Lancet (1990) 336:1442–1443.
   Google Scholar
• Lox ASF, MA OCK, CHAN TM, LA: CL, CHUNG HT, No CPL, LAM JSC: Overestima-tion of the prevalence of antibody to hepati-tis C virus in retrospective studies on stored sera. Hepatology (1991) 14(5):756–762.
   PubMedGoogle Scholar
• MURAISO K, HIJIKATA M, OHKOSHI S, CHO MJ, ICKUCHI M, KATO N, SHLMOTOHNO, K: A structural protein of hepatitis C virus ex-pressed in E. coli facilitates accurate detec-tion of hepatitis C virus. Biochem. Biophys. Res. Comm. (1990) 172(2):511–516.
   PubMedGoogle Scholar
• CHIBA J, OHBA H, MATSUURA Y, WATANABE Y, KATAYAMA T, Kuwait S, SAITO I, MIYA-MURA T: Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core pro-tein molecularly expressed by a recombinant baculovirus. Proc. Natl. Acad. Sci. USA (1991) 88:4641–4645.
   PubMedGoogle Scholar
• HARADA S. WATANABE Y, TAKEUCHI K, SUZUKI T, KATAYAMA T, TAKEBE Y, SAITO I, MIYAMURA T: Expression of processed core protein of hepatitis C virus in mammalian cells. J. Virol. (1991) 65(6):3015–3021.
   PubMedGoogle Scholar
• NASOFF MS, ZEBEDEE SL, INCHAUSPE G, PRINCE AM: Identification of an inunun-°dominant epitope within the capsid protein of hepatitis C virus. Proc. Natl. Acad. Sci. USA (1991) 88:5462–5466.
   PubMedGoogle Scholar
• YOSHIKAWA A, TAKAHASHI K, KismimoTo S, TSUDA F, AKAIIANE Y, NArro S, TANAKA T, YOSHIZAWA H, YAMASAIU M, OKAMOTO H, MIYAKAWA Y, MAYUMI M: Serocliagnosis of hepatitis C virus infection by ELISA for antibodies against the putative core protein (p20c) expressed in Escherichia coll. J. Im-munol. Meth. (1992) 148:143–150.
   PubMedGoogle Scholar
• MUNEKATA E, KOBAYASHI N, EIKI J, FUJINAKA H, AKUTSU T, TAICENOUCHI T, TANIGUCHI S, NIWA M, TANAKA T, MACHIDA A, MAYUMI M: Epitope-mapping of hepatitis C virus constituting proteinl. In: Peptide Chemistry 1990. (1991), Shimonishi Y (Ed), Protein Re-search Foundation, Osaka, pp211–214.
   Google Scholar
• OKAMOTO H, MUNEKATA E, TSUDA F, TAKA-HASHI K, YOTSUMOTO S. TANAKA T, TACHI-BANA K, SUGAI Y, MIYAKAWA Y, MAYUMI M: Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hep-atitis C virus with a synthetic oligopeptide. Japan. J. Exp. Med. (1990) 60:223–233.
   Google Scholar
• HOSEEN B, FANG CT, POPOVSKY MA, YE J, ZHANG M, WANG CY: Improved serodiagno-sis of hepatitis C virus infection with syn-thetic peptide antigen from capsid protein. Proc. Natl. Acad. Sci. USA (1991) 88:3647–3651.
   PubMedGoogle Scholar
• OICAMOTO H, TSUDA F, MACHEDA A, MUNEKATA E, AICAHANE Y, SUGAI Y, MASHIKO K, MITSUI T, TANAKA T, MIYAKAWA Y, MAYUMI M: An-tibodies against synthetic oligopepddes de-duced from the putative core gene for the diagnosis of hepatitis C virus infection. Hep-atology (1992) 15(2):180–186.
   PubMedGoogle Scholar
• YUKI H, HAYASHI N, KASAHARA A, HAGIWARA H, UEDA K, FUSAMOTO H, ICAmADA T: An-tibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease. J. Med Virol. (1992) 38:86–91
   PubMedGoogle Scholar
• CHING WM, WYCHOWSKI C, BEACH MJ, WANG H, DAVIES CL, CARL M, BRADLEY DW, ALTER HJ, FEINSTONE SM, SHIH JWK: Inter-action of immune sera with synthetic pep-tides corresponding to the structural protein region of hepatitis C virus. Proc. NatL Acad. Sci. USA (1992) 89:3190–3194.
   PubMedGoogle Scholar
• SALLBERG M, RUDEN U, WAHREN B, MAGNIUS LO: Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the iso-types and the recognition site. Immunol. Lett. (1992) 33:27–34.
   PubMedGoogle Scholar
• SALLBERG M, RUDEN U, WAHREN B, MAGNIUS LO: Immunodominant region within the hepatitis C virus core and putative matrix proteins. J. Clin. MicrobioL (1992) 30:1989–1994.
   PubMedGoogle Scholar
• ARIMA T, TAKAMIZAWA A, MORI C, MURA-KAMI S. KAn C, FuGrrA J: A lambda gni- cDNA clone specific for chronic hepatitis C generated from pooled serum presumably infected by hepatitis C virus. Gastroenterol. Japon. (1989) 24:545–548.
   Google Scholar
• ARIMA T, MORI C, TAKAMIZAWA A, Siumo-MURA H, TSUJI T: A cDNA clone encoding a peptide highly specific for hepatitis infection. Gastroenterol. Japan (1990) 25(2):1110–1114.
   Google Scholar
• MAENO M, ICAMINAKA K, SUGIMOTO H, Esumi M, HAYASHI N, KOMATSU K, ABE K, SEKIGUCHI S, YANO M, MIZUNO K, SHIKATA T: A cDNA clone closely associated with non-A, non-B hepatitis. NucL Acids Res. (1990) 18(9):2685–2689.
   PubMedGoogle Scholar
• OSHIMA M, TSUCHIYA M, YAGASAKI M, ORITA T, HASEGAWA M, TOMONOH K, KOJIMA T, HIRATA Y, YAMAMOTO 0, SHO Y, MAEDA E, ARIMA T: cDNA clones of Japanese hep-atitis C virus genomes derived from a single patient show sequence heterogeneity. J. Gen. ViroL (1991) 72:2805–2809.
   PubMedGoogle Scholar
• MCHUTCHISON JG, PERSON JL, GOVINDARAJAN S, VALINLUCK B, GORE T, LEE SR, NELLES M, POLITO A, CHIEN D, DINELLO R, QUAN S, Kuo G, REDEKER AG: Improved detection ofhepatitis C virus antibodies in high-risk pop- ulations. Hepatology (1992) 15(1):19–25.
   PubMedGoogle Scholar
• PUOTI M, ZONARO A, RAVAGGI A, MARIN MG, CASTELNUOVO F, CARIANTI E: Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus in-fection. Hepatology (1992) 16(4):877–881.
   PubMedGoogle Scholar
• VAN DER POEL CL, CUYPERS HTM, REES1NK 11W, WEINER AJ, QUAN S. DINELLO R, VAN BOVEN JJP, WINKEL I, MULDER-FOL10ERTS D, EXEL-OEHLERS PJ, SCHAASBERG W, LEENT-VAAR-KUYPERS A, POLITO A, HOUGHTON M, LELIE PN: Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 337:317–319.
   Google Scholar
• HUIKATA M, KATO N, OOTSUYAMA Y, NAKA-GAWA M, OHKOSHI S. SHIMOTOHNO K: Hyper-variable regions in the putative gjycoprotein of hepatitis C virus. Biochem. Biophys. Res. Comm. (1991) 175(1):220–228.
   PubMedGoogle Scholar
• WEINER A.1, BRAUER MJ, ROSENBLATT J, RICHMAN KB, TUNG J, CRAWFORD K, BONIN° F, SARACCO G, CHOO QL, HOUGHTON M, HAN JH: Variable and hypervariable domains are found in the regions of HCV correspond-ing to the flavivirus envelope and NS1 pro-teins and the pestivirus envelope glycopro-teins. Virology (1991) 180:842–848.
   PubMed Web of Science ®Google Scholar
• KREMSDORF D, PORCHON C, KIM JP, REYES GR, BRECHOT C: Partial nucleotide sequence analysis of a French hepatitis C virus: im-plications for HCV genetic variability in the E2/NS1 protein. J. Gen. Virol. (1991) 72:2557–2561.
   PubMedGoogle Scholar
• Fuois K, Morz M, SCHREIER E, ZACHOVAL R, DE1NHARDT F, ROGGENDORF M: Char-acterization of nucleotide sequences from European hepatitis C virus isolates. Gene (1991) 103:163–169.
   PubMedGoogle Scholar
• KATO N, OOTSUYAMA Y, TANAKA T, NAKAGAWA M, NAKAZAWA T, MURAISO K, OHKOSHI S, HIJIKATA M, SHIMOTOHNO K: Marked se-quence diversity in the putative envelope proteins of hepatitis C virus. Virus Res. (1992) 22:107–123.
   PubMed Web of Science ®Google Scholar
• WEINER Al, GEYSEN HM, CHRISTOPHERSON C, HALL JE, MASON TJ, SARACCO G, BONIN°F, CRAWFORD K, MARION CD, CRAWFORD KA, BRUNETTO M, BARR PJ, MIYAMURA T, MCHUTCHINSON J, HOUGHTON M: Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein vari-ants: Potential role in chronic HCV in-fections. Proc. Natl. Acad. Sci. USA (1992) 89:3468–3472.
   PubMed Web of Science ®Google Scholar
• MITA E, HAYASHI N, UEDA K, KASAHARA A, FUSAMOTO H, TAKAMIZAWA A, MATSUBARA K, OICAYAMA H, ICAMADA T: Expression of MBP-HCV NS1/E2 fusion protein in E. coil and detection of anti-NS1/E2 antibody in type C chronic liver disease. Biochem. Bio- phys. Res. Comm. (1992) 183(3):925–930.
   Google Scholar
• INOUE Y, SUZUKI R, MATSUURA Y, HARADA S, CHIBA J, WATANABE Y, SAITO I, MIYAMURA T: Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver dis-eases. J. Gen. Virol. (1992) 73:2151–2154.
   PubMedGoogle Scholar
• MACHIDA A, OHNUMA H, TSUDA F, MUNEKATA E, TANAKA T, AKAHANE Y, OKAMOTO H, MISHIRO S: Two distinct subtypes of hepati-tis C virus defined by antibodies directed to the putative core protein. Hepatology (1992) 16(4):886–891.
   PubMedGoogle Scholar
• TSUKIYAMA-KOHARA K, YAMAGUCHI K, MAKI N, OHTA Y, MIKI K, MIZOKAMI M, OHBA KI, TANAKA S, HATTORI N, NOMOTO A, KOHARA M: Antigenicities of group I and group II hepatitis C virus polypeptides - molecular basis of diagnosis. Virology (1993) 192:430–437.
   PubMedGoogle Scholar
• 'CANA' K, ICAKo M, OICAMOTO H: HCV geno-types in chronic hepatitis C and response to interferon. Lancet (1992) 339:1543.
   Google Scholar